PanGen Biotech Inc. (KOSDAQ:222110)

PanGen Biotech Revenue

In the year 2025, PanGen Biotech had annual revenue of 13.42B KRW, down -8.56%. PanGen Biotech had revenue of 2.48B in the quarter ending December 31, 2025, a decrease of -42.86%.

• Revenue: 13.42B
• Revenue Growth: -8.56%
• P/S Ratio: 6.02
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 80.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.42B	-1.26B	-8.56%
Dec 31, 2024	14.67B	7.36B	100.58%
Dec 31, 2023	7.32B	814.47M	12.53%
Dec 31, 2022	6.50B	-1.43B	-18.08%
Dec 31, 2021	7.94B	1.74B	28.18%